ACM
AGN

Atlanta Capital Management’s Allergan Inc AGN Stock Holding History

Atlanta Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-270,226
Closed -$57.4M – 209
2014
Q4 		$57.4M Sell
270,226
-159,867
-37% -$31.8M 0.39% 87
2014
Q3 		$76.6M Sell
430,093
-101,947
-19% -$16.9M 0.55% 74
2014
Q2 		$90M Sell
532,040
-308,708
-37% -$48.1M 0.62% 68
2014
Q1 		$104M Sell
840,748
-268,206
-24% -$32.7M 0.72% 57
2013
Q4 		$123M Sell
1,108,954
-196,213
-15% -$18.7M 0.81% 47
2013
Q3 		$118M Sell
1,305,167
-27,373
-2% -$2.46M 0.84% 47
2013
Q2 		$112M Buy
+1,332,540
New +$138M 0.85% 48

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Atlanta Capital Management's AGN Position: Q1 2015 in Review

Atlanta Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 270,226 shares — an estimated $57.4M sold.

Atlanta Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $123M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Atlanta Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Atlanta Capital Management sold 270,226 Allergan Inc shares in Q1 2015, an estimated $57.4M.
  • Atlanta Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Atlanta Capital Management's Allergan Inc position peaked at $123M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Atlanta Capital Management's 13F filing for Q1 2015, filed 14 May 2015.